MGNX - MacroGenics GAAP EPS of $0.28 beats by $0.29 revenue of $10.39M misses by $41.73M
2023-11-06 16:08:57 ET
More on MacroGenics
- MacroGenics' Undervalued Potential In Oncology Therapeutics
- MacroGenics, Inc. 2023 Q2 - Results - Earnings Call Presentation
- MacroGenics, Inc. (MGNX) Q2 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on MacroGenics
- Historical earnings data for MacroGenics
For further details see:
MacroGenics GAAP EPS of $0.28 beats by $0.29, revenue of $10.39M misses by $41.73M